peginterferon alfa-2a
MV21371
Phase 3 small_molecule completed
Quick answer
peginterferon alfa-2a for Hepatitis C, Chronic is a Phase 3 program (small_molecule) at Hoffmann-La Roche with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Hepatitis C, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed